Dr. Brian C. Toy, MD

Dr. Toy practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Toy's NPI, 1659639540, was assigned on April 27, 2012. Dr. Toy graduated from UCSF School of Medicine in 2012. Dr. Toy holds California license A126637.

Dr. Toy's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Toy's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Toy is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Toy to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toy practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Toy's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Toy is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Toy is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, glaucoma, hypertensive retinopathy, inflammation of iris and retinal occlusion among the conditions Dr. Toy treats.

CMS data shows 926 Medicare services from Dr. Toy across 9 procedure codes in 2024, for 161 Medicare patients. Medicare paid $50,329 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 161 Medicare patients who saw Dr. Toy in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 39% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Toy's median patient age at 65, with 51% women.

In 2024, Dr. Toy wrote 435 Medicare Part D claims for 89 patients. 63% of them were for generic drugs. CMS names the drug for 338 of them, across 11 drugs with 11 or more claims each, at $208,113 in total drug cost. In 2023, CMS named 226 claims across 9 drugs.

Dr. Toy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Toy, published from 2012 to 2025. 2012 was the busiest year, with 3. Dr. Toy's most frequent co-authors are Tyler Francis Aguinaldo, MD, Mashal Akhter, MD and Hossein Ameri, MD.

CMS Open Payments shows 139 general payments to Dr. Toy from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $7,309.

Dr. Toy graduated from UCSF School of Medicine in 2012.

Dr. Toy is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.